News

Fortrea Earns Top Rank in Everest's PV Operations Assessment

Fortrea Earns Top Rank in Everest's PV Operations Assessment

Fortrea Achieves Recognition in Pharmacovigilance Operations

In a significant achievement, Fortrea (Nasdaq: FTRE), a prominent contract research organization based in Durham, North Carolina, has been named a "Leader" in the Everest Group's Pharmacovigilance Operations PEAK Matrix Assessment 2025. This recognition underscores Fortrea's excellence in providing pharmacovigilance services, particularly in both pre- and post-approval phases. The assessment evaluates various providers based on their impact on the market and their capabilities, affirming Fortrea's position at the forefront of the industry.

Commitment to Patient Safety

Mark Morais, the Chief Operations Officer and President of Fortrea Clinical Development, emphasized the company's mission to expedite the delivery of life-altering treatments to patients. "Our commitment is reflected in our leadership within the pharmacovigilance space," he stated. Fortrea is dedicated to global end-to-end safety solutions encompassing the full product life cycle from early phases through to post-approval. By adhering to a first-time-right methodology, they not only prioritize patient care but also ensure the needs of healthcare professionals and regulatory bodies are met.

Insight from Everest Group

The Everest Group's comprehensive report highlights that 29 leading PV operations providers were examined for their service offerings and strategic investments. This rigorous evaluation process involved extensive client reference checks and continuous monitoring of the pharmacovigilance operations market. According to Vandana Sharma, a Practice Director at Everest Group, as the complexities of pharmacovigilance increase, sponsors are increasingly choosing partners that deliver integrated scientific insight and end-to-end strategic support.

Fortrea’s Unique Strengths

Fortrea distinguishes itself through its dual-strength capabilities in pharmacovigilance. With expertise across over 60 therapeutic areas, they provide thorough safety services throughout clinical stages as well as robust post-marketing operations. Their framework incorporates global Qualified Person Responsible for Pharmacovigilance coverage, combined with innovative technological advancements. Clients frequently cite Fortrea’s scientific depth, global reach, and scalable solutions as key strengths that contribute to its leadership position.

Enhanced Safety Operations

The safety team at Fortrea consists of dedicated professionals operating on a global scale. They utilize industry-standard safety systems and proprietary automation to optimize operational efficiencies and cater to country-specific requirements effectively. Fortrea’s array of safety offerings includes a medical contact center, case processing, medical reviews, aggregate reporting, safety surveillance, and comprehensive QPPV support.

Innovation and Development

As a leader in the life sciences sector, Fortrea partners with both emerging and established pharmaceutical and biotechnology companies. Their services span clinical trial management and consulting in various therapeutic areas, leveraging three decades of extensive experience. With a commitment to scientific rigor and innovative solutions, Fortrea aims to transform healthcare and accelerate the development of therapies that can change lives.

Engagement with the Community

The commitment of Fortrea to engage actively with healthcare providers, stakeholders, and the broader community is evident through various initiatives. As they expand their operations into different global markets, Fortrea continues to strengthen relationships that foster collaboration, ensuring that patient safety remains a top priority.

Frequently Asked Questions

What does Fortrea do?

Fortrea is a global contract research organization that provides comprehensive clinical development solutions to life sciences companies.

What recognition has Fortrea received recently?

Fortrea has been recognized as a leader in pharmacovigilance operations by Everest Group in their 2025 PEAK Matrix Assessment.

Why is pharmacovigilance important?

Pharmacovigilance is crucial for monitoring the safety of medical products, ensuring patient safety, and compliance with regulatory standards.

How does Fortrea ensure safety?

Fortrea employs a dedicated global safety team utilizing standardized systems and innovative automation for efficient safety management.

Where can I learn more about Fortrea's services?

More information on Fortrea's clinical solutions and safety services can be found on their official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PAG, HOWL and PSNL Deals Face Fresh Shareholder Checks

Updated Category News Views 60

Three proposed takeovers, three very different headaches, and one familiar question that never gets old: are regular shareholders actually receiving the best available deal? On Nov. 20, 2026, investor-rights law firm Halper Sadeh LLC said it was investigating the proposed transactions involving Penske Automotive Group, Werewolf Therapeutics and Personalis for potential...

Continue Reading
Birla Carbon's Rayong Bet Tightens Asian Supply Lines

Updated Category News Views 130

Rayong just became a much louder pin on Asia's industrial map. Birla Carbon has inaugurated a 120 kMT carbon black plant in Thailand, and the significance is bigger than a ribbon-cutting photo. This is a capacity-and-location move aimed squarely at the uncomfortable part of industrial supply chains: customers need material when they need it, not after it has spent weeks...

Continue Reading
Trip.Best Expands Global Travel Discovery Footprint

Updated Category News Views 123

Sydney just became the map pin for a fairly serious travel-content land grab. Trip.Best, Trip.com Group's ranking brand, has rolled out its 2027 Annual Rankings with coverage of all seven continents for the first time. This is not an earnings release, and nobody should pretend a hotel list magically turns into revenue by lunchtime. Still, the jump from 85 to 98 annual...

Continue Reading
Mimic Bets Virtual Patching Can Calm AI Patch Chaos

Updated Category News Views 119

Three ugly outages in four days can make even hardened technology buyers reconsider the sacred ritual of “patch immediately.” Mimic’s new Virtual Patching offering arrives squarely in that uncomfortable gap: a vulnerability is known, attackers may be moving fast, and the proper vendor update still needs testing before somebody detonates production. The company’s...

Continue Reading
Veterinary Biologics Growth Has a Valuable Catch Ahead

Updated Category News Views 55

Pet allergies and livestock disease are hardly glamorous, yet they are becoming a durable spending lane. The veterinary biologics market is projected to rise from $2.85 billion in 2026 to $3.69 billion by 2031, a 5.3% compound annual growth rate. That is not the kind of growth figure that makes anyone pound the table, and frankly it should not. It is the sort that can...

Continue Reading
Label-Free Detection Has a Solid, Narrow Growth Lane

Updated Category News Views 77

Biologics labs are turning into a far better hunting ground for analytical equipment than the old, broad-brush research story suggests. Label-free detection is not a giant market, and nobody should dress it up as one. But the projected move from $0.58 billion in 2026 to $0.85 billion by 2031 points to a useful 8.1% annual growth lane, driven by work researchers genuinely...

Continue Reading
FFR Adds Academic and Commercial Muscle to Its Board

Updated Category News Views 65

Robotics boards can get crowded with lofty nouns fast, and FFR just added another one with some real-world connective tissue behind it. Carolyn Kissane, associate dean at NYU's Center for Global Affairs, has joined as an independent director. The appointment is not a product launch, a contract, or revenue. It is a governance move. Still, in a business trying to weld...

Continue Reading
Oatly’s $4.13 Tender Offer Is a Legal Detour, Not a Sale

Updated Category News Views 25

A $4.13 cash offer trading against a $7.17 close is the sort of thing that makes investors squint hard, and Verlinvest is practically waving a flag telling them why. This is not a conventional attempt to buy Oatly Group AB. It is a technical tender offer built to satisfy Swedish takeover rules while Verlinvest buys out its joint-venture partner’s interest in Oatly’s...

Continue Reading
Ampace Targets AI Data Centre UPS Safety Needs in Paris

Updated Category News Views 94

Backup power gets interesting only after the grid has disappointed everybody. At Data Centre World Paris 2026, Ampace put its attention on that ugly, split-second handoff: utility power drops, a UPS has to catch the load immediately, and nobody operating an AI data centre gets to shrug if it does not. A Narrow Job With Brutal Consequences The company showcased its PU200...

Continue Reading
CVS Puts Youth Soccer Stories on Its Store Shelves

Updated Category News Views 60

Two kids with real community ties just got a megaphone most grown-ups never receive. CVS Pharmacy has named Caroline, 9, of Holmes Beach, Florida, and Zoe, 12, of Los Angeles, as the first grand-prize winners of its Home Team Heroes youth soccer contest. Each player’s selected nonprofit soccer organization will receive a $25,000 grant, while their stories will appear on...

Continue Reading

Top 5 Most Recently Viewed Articles

Accessibility Insights: Boosting Website Rankings Effectively

Updated Category News Views 152

Accessibility Insights for Website Rankings A recent study has highlighted a compelling correlation between website accessibility and search engine ranking. Through extensive research, it has become increasingly clear that adhering to accessibility guidelines significantly impacts organic search success. This analysis underscores the importance of making websites more...

Continue Reading
CVS Health and Cigna Introduce 2025 Medicare Advantage Plans

Updated Category News Views 409

Back in 2025, CVS Health and Cigna took center stage with their new Medicare Advantage plans aimed squarely at seniors. The big pitch? Some members could enjoy $0 monthly premiums for essential prescription drugs—sounds great, right? But let's unpack that. Enrollment Window: Timing is Everything The enrollment period was set from October 15 to December 7, a critical...

Continue Reading
Kodiak AI: Pioneering the Future of Autonomous Freight Logistics

Updated Category News Views 329

Kodiak AI and Ares Acquisition Corporation II Create a New Era in Autonomous Freight Kodiak AI, Inc., a revolutionary player in the autonomous vehicle space, is ready to ignite the future of freight logistics with its recent business combination with Ares Acquisition Corporation II. This pivotal step not only solidifies Kodiak's standing as a leader in AI-driven...

Continue Reading
TRON DAO Enhances DeFi Ecosystem through Chainlink Partnership

Updated Category News Views 97

TRON DAO Joins Forces with Chainlink for DeFi Advancement The TRON network is rapidly becoming a significant player in the decentralized finance (DeFi) space, boasting one of the largest DeFi economies globally. By collaborating with Chainlink through the Chainlink Scale program, TRON DAO is set to accelerate growth and improve adoption in its ecosystem. Chainlink Data...

Continue Reading
Canton Fair Showcases Sustainable Innovations for a Greener Future

Updated Category News Views 387

Canton Fair Showcases Sustainable Innovations for a Greener Future The ongoing Canton Fair has positioned itself as a leader in promoting environmental sustainability and innovation. A remarkable 10,040 companies are showcasing their offerings, highlighting over 300,000 green and low-carbon products. This huge gathering emphasizes the importance of eco-friendly solutions...

Continue Reading